High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-ß-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center.
Clin Infect Dis
; 63(7): 954-958, 2016 10 01.
Article
in En
| MEDLINE
| ID: mdl-27313265
ABSTRACT
Resistance to the novel ß-lactam/ß-lactamase inhibitor combination ceftazidime-avibactam (CAZ-AVI) among carbapenem-resistant Enterobacteriaceae (CRE) has infrequently been reported in the United States. We report unexpectedly high rates of resistance to CAZ-AVI in CRE bloodstream isolates at our institution associated with the nonoutbreak spread of New Delhi metallo-ß-lactamase in diverse Enterobacteriaceae species.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ceftazidime
/
Bacteremia
/
Enterobacteriaceae
/
Enterobacteriaceae Infections
/
Azabicyclo Compounds
/
Anti-Bacterial Agents
Type of study:
Diagnostic_studies
Limits:
Adult
/
Aged
/
Child, preschool
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2016
Type:
Article